Access cutting-edge cancer treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access cancer specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a KRAS G12C mutation.
Sponsor: Mirati Therapeutics Inc.
Check if you qualify for this cancer clinical trial in Phoenix, AZ
If you're searching for cancer treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.